<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Clinics (Sao Paulo)</journal-id><journal-title-group><journal-title>Clinics</journal-title></journal-title-group><issn pub-type="ppub">1807-5932</issn><issn pub-type="epub">1980-5322</issn><publisher><publisher-name>Hospital das Cl&#x000ed;nicas da Faculdade de Medicina da Universidade de S&#x000e3;o Paulo</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">21808872</article-id><article-id pub-id-type="pmc">3129971</article-id><article-id pub-id-type="doi">10.1590/S1807-59322011000600020</article-id><article-id pub-id-type="publisher-id">cln_66p1041</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Science</subject></subj-group></article-categories><title-group><article-title>Frequency of genetic polymorphisms of <italic>PXR</italic> gene in the Brazilian population</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Moreira</surname><given-names>Ricardo P P</given-names></name><xref ref-type="aff" rid="af1-cln_66p1041">I</xref></contrib><contrib contrib-type="author"><name><surname>Jorge</surname><given-names>Alexander A L</given-names></name><xref ref-type="aff" rid="af2-cln_66p1041">II</xref></contrib><contrib contrib-type="author"><name><surname>Mendonca</surname><given-names>Berenice B</given-names></name><xref ref-type="aff" rid="af1-cln_66p1041">I</xref></contrib><contrib contrib-type="author"><name><surname>Bachega</surname><given-names>T&#x000e2;nia A S S</given-names></name><xref ref-type="aff" rid="af1-cln_66p1041">I</xref></contrib><aff id="af1-cln_66p1041"><label>I</label>Unidade de Endocrinologia do Desenvolvimento, Laboratrio de Hormnios e Gentica Molecular LIM 42, Disciplina de Endocrinologia da Faculdade de Medicina da Universidade de S&#x000e3;o Paulo, S&#x000e3;o Paulo, Brazil. </aff><aff id="af2-cln_66p1041"><label>II</label>Unidade de Endocrinologia Gentica LIM 25, Disciplina de Endocrinologia da Faculdade de Medicina da Universidade de S&#x000e3;o Paulo, S&#x000e3;o Paulo, Brazil. </aff></contrib-group><author-notes><corresp id="c1-cln_66p1041">E-mail: <email>tbachega@usp.br</email> Tel.: <phone>55 11 30697512</phone></corresp></author-notes><pub-date pub-type="ppub"><month>6</month><year>2011</year></pub-date><volume>66</volume><issue>6</issue><fpage>1041</fpage><lpage>1044</lpage><history><date date-type="received"><day>25</day><month>2</month><year>2011</year></date><date date-type="rev-recd"><day>16</day><month>3</month><year>2011</year></date><date date-type="accepted"><day>16</day><month>3</month><year>2011</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2011 Hospital das Cl&#x000ed;nicas da FMUSP</copyright-statement><copyright-year>2011</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>INTRODUCTION:</title><p>PXR polymorphisms have been implicated in modulating <italic>CYP3A4</italic> and PXR expression, potentially accounting for interindividual differences in drug metabolism. The prevalence of PXR polymorphisms varies among ethnic groups and data on the allelic distribution in the highly mixed Brazilian population is lacking. The aim of this study was to analyze genetic variations in the PXR gene in Brazilians and to compare the results to other ethnic groups.</p></sec><sec><title>METHODS:</title><p>DNA samples from 117 healthy Brazilians underwent PCR amplification and sequencing.</p></sec><sec><title>RESULTS:</title><p>Eleven polymorphisms were identified, 3 of which are highly associated with differences in <italic>CYP3A4</italic> expression. We also identified 1 new synonymous variant in 1.3% of the alleles. Among the functional polymorphisms, &#x02013;25913 C&#x0003e;T and &#x02013;6994T&#x0003e;C occurred at a higher frequency compared to the African alleles (p &#x0003c; 0.05) but at a lower frequency compared to Caucasian alleles. The 8055 C&#x0003e;T allele was found at a similar frequency to those described in Caucasians and Africans (p &#x0003e; 0.05).</p></sec><sec><title>CONCLUSION:</title><p>We observed that functional variants of the PXR were frequent in our sample of the Brazilian population. Our results suggest that PXR gene variants may be of interest in pharmacogenetic studies involving Brazilians.</p></sec></abstract><kwd-group><kwd>Pharmacogenetics</kwd><kwd>Allelic distribution</kwd><kwd>Brazilian population</kwd><kwd>Genetic variation</kwd></kwd-group><counts><page-count count="4"/></counts></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>The interindividual variability in human drug metabolism may be genetically determined by allelic variance in genes encoding P450 proteins and nuclear receptors.<xref ref-type="bibr" rid="b1-cln_66p1041">1</xref>-<xref ref-type="bibr" rid="b4-cln_66p1041">4</xref> Cytochrome P450s metabolize approximately 80% of clinical drugs and polymorphisms in the <italic>CYP3A4</italic> gene have been previously investigated due to its involvement in the metabolism of more than 50% of drugs. Despite the large interindividual differences in <italic>CYP3A4</italic> expression, polymorphisms that impair enzyme activity seem to be rare.<xref ref-type="bibr" rid="b5-cln_66p1041">5</xref>-<xref ref-type="bibr" rid="b7-cln_66p1041">7</xref></p><p><italic>CYP3A4</italic> expression is mainly induced by the pregnane X receptor (PXR),<xref ref-type="bibr" rid="b8-cln_66p1041">8</xref>-<xref ref-type="bibr" rid="b10-cln_66p1041">10</xref> a member of the orphan nuclear receptor subfamily and the main transcriptional regulator of cytochrome P4503A enzymes.<xref ref-type="bibr" rid="b8-cln_66p1041">8</xref>,<xref ref-type="bibr" rid="b9-cln_66p1041">9</xref> The activation of PXR initiates in the cytoplasm. After exposure to ligands, PXR dimerizes with the retinoic acid receptor (RXR) and binds to nuclear receptor response elements in the upstream regulatory regions of target genes. These genes encode drug-metabolizing enzymes such as <italic>CYP3A4</italic> and drug transporters,<xref ref-type="bibr" rid="b11-cln_66p1041">11</xref> which are the main regulators in the uptake and transformation of many prescribed medicines.</p><p>Several <italic>PXR</italic> (also known as <italic>NR1I2</italic>) polymorphisms have been identified that influence the level of <italic>PXR</italic> expression and, therefore, indirectly regulate its target genes.<xref ref-type="bibr" rid="b4-cln_66p1041">4</xref>,<xref ref-type="bibr" rid="b12-cln_66p1041">12</xref> These polymorphisms account for the wide variability of CYP3A4 levels in the population.<xref ref-type="bibr" rid="b4-cln_66p1041">4</xref>,<xref ref-type="bibr" rid="b13-cln_66p1041">13</xref> The functional effects of these polymorphisms include aberrant DNA binding and alterations in the transactivation and expression of downstream target genes.<xref ref-type="bibr" rid="b4-cln_66p1041">4</xref>,<xref ref-type="bibr" rid="b12-cln_66p1041">12</xref>       </p><p>While the allelic distribution of the <italic>PXR</italic> gene varies widely among different ethnic groups,<xref ref-type="bibr" rid="b13-cln_66p1041">13</xref>-<xref ref-type="bibr" rid="b17-cln_66p1041">17</xref> it has yet to be studied in the highly mixed Brazilian population. Here we analyze the frequency of <italic>PXR</italic> variants in a sample of healthy Brazilian subjects. We also compare the frequencies of <italic>PXR</italic> polymorphisms to those described in Asians, Caucasians, and Africans in order to determine whether <italic>PXR</italic> variants should be evaluated in pharmacogenetic studies involving Brazilian subjects.</p><sec><title>Subjects</title><p>The study protocol was approved by the Ethical Committee of S&#x000e3;o Paulo University. Written consent was obtained from all subjects. Healthy volunteers consisted of 76 females and 41 males with a mean age 25.8 &#x000b1; 11.8 years. The self-reported ethnicity of this cohort was 87.2% Caucasian and 12.8% African. In addition, 88% were from the southeast, 8.5% from the northeast, and 3.5% from the southern region of Brazil.</p></sec></sec><sec sec-type="methods"><title>METHODS</title><p>DNA samples from all subjects were obtained from peripheral blood leukocytes using a salting out procedure. All coding regions of the <italic>PXR</italic> gene were analyzed in addition to three variants in non-coding regions that had a minor allele frequency of at least &#x02265; 0.10 in other ethnic groups. We also looked for three variants, which modified the PXR and/or CYP3A4 expression, previously described in non-coding regions with a minor allele frequency &#x02265; 0.10 in other ethnic groups.<xref ref-type="bibr" rid="b4-cln_66p1041">4</xref>,<xref ref-type="bibr" rid="b17-cln_66p1041">17</xref> The <italic>PXR</italic> gene was amplified as previously described.<xref ref-type="bibr" rid="b4-cln_66p1041">4</xref>,<xref ref-type="bibr" rid="b18-cln_66p1041">18</xref> The amplified products were sequenced using the Big Dye Terminator Sequencing Kit&#x02122; (Applied Biosystem, Inc., Foster City, CA, USA) and capillary electrophoresis was conducted on an ABI PRISM 3100 sequencer (Applied Biosystem, Inc.). Sequence traces were analyzed using Sequencher (version 4.5 build 1416) and assembled to the reference (NCBI accession number AF364606).</p><sec><title>Statistical Analysis</title><p>When appropriate, identified allele frequencies were compared to the expected normal distribution in a population (Hardy-Weinberg equilibrium) by using a goodness-of-fit <italic>x</italic><sup>2</sup> test.</p><p>Differences in allele frequencies between ethnic groups were analyzed using the <italic>x</italic><sup>2</sup> test. Values of p &#x0003c; 0.05 were considered to be significant.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>The allelic frequencies of <italic>PXR</italic> polymorphisms that we identified in this study are shown in <xref ref-type="table" rid="t1-cln_66p1041">Table 1</xref> along with previously published data from Asian, Caucasian, and African populations. The genotypic frequencies that we found are listed in <xref ref-type="table" rid="t2-cln_66p1041">Table 2</xref>. All polymorphisms were in Hardy-Weinberg equilibrium. We identified 11 polymorphisms (<xref ref-type="table" rid="t1-cln_66p1041">Tables 1</xref> and <xref ref-type="table" rid="t2-cln_66p1041">2</xref>), one of which is a new synonymous variant located in exon 4 (4306 C&#x0003e;G) that was present in 1.3 % of Brazilian alleles. Eight polymorphisms were identified in the coding regions of the <italic>PXR</italic> gene and 3 polymorphisms in non-coding regions. Of the variants identified, 8055 C&#x0003e;T, -25913 C&#x0003e;T, and -6994 C&#x0003e;T are known to be associated with functionality.</p><p>The 8055 C&#x0003e;T (rs2276707) variant was found in 12.5% of alleles, which is similar to its frequencies in Caucasian and African alleles of 15% and 18% (p &#x0003e; 0.05),<xref ref-type="bibr" rid="b12-cln_66p1041">12</xref> respectively, but lower than its frequency in Chinese alleles of 45% (p &#x0003c; 0.05).<xref ref-type="bibr" rid="b19-cln_66p1041">19</xref> The -25913 C&#x0003e;T (rs1523130) variant occurred in 50% of the Brazilian alleles, which is less frequent than in Caucasians (70%, p &#x0200a;=&#x0200a; 0.003, 95% CI: 0.66-0.76) but more frequent than in Africans (28%, p &#x0003c; 0.001, 95% CI: 0.49-0.61). The -6994 C&#x0003e;T (rs2472677) polymorphism was found in 46% of the Brazilian alleles, which is a higher frequency than in Africans (38.1%, p &#x0200a;=&#x0200a; 0.03, 95% CI: 0.80-0.85) but a lower frequency than in Caucasians (62%, p &#x0200a;=&#x0200a; 0.01, 95% CI: 0.70-0.79).</p><p>The 79 C&#x0003e;T (rs12727613) polymorphism was found in 2.1% of Brazilian alleles. This variant is significantly more frequent in African alleles (20%, p &#x0003c; 0.001) and not present in Caucasians or Asians. The 106 G&#x0003e;A (rs12721607) polymorphism, which is absent in Asians, was found in 1.3% of alleles in this population, similar to its frequencies in Caucasians and Africans of 5% and 4%, respectively (p &#x0003c; 0.05). The 4321 G&#x0003e;A (rs12721608) polymorphism is absent in Africans but present in Brazilians at a similarly low frequency as that found in Caucasians (p &#x0003c; 0.05). The other five polymorphisms were detected at a frequency lower than 1% [4447 T&#x0003e;C (rs12721611), 4499 C&#x0003e;T (rs12721600), 4773 G&#x0003e;A (rs12721612), and 8528 G&#x0003e;A (rs59152710)].</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p><italic>PXR</italic> polymorphisms have been implicated in modulating <italic>CYP3A4</italic> and <italic>PXR</italic> expression, potentially accounting for interindividual differences in drug metabolism.<xref ref-type="bibr" rid="b20-cln_66p1041">20</xref> These variants impact drug response and some types of drug interactions by affecting serum levels of the medicines and endogenous compounds, which can include PXR ligands and substrates of enzymes and drug transporters.<xref ref-type="bibr" rid="b13-cln_66p1041">13</xref> The distribution of allelic variants in the <italic>PXR</italic> gene varies widely among different ethnic groups,<xref ref-type="bibr" rid="b12-cln_66p1041">12</xref>,<xref ref-type="bibr" rid="b14-cln_66p1041">14</xref> which helps to explain variations in the pharmacokinetics and pharmacodynamics of drugs that are PXR ligands.</p><p>This study was carried out in order to determine the frequency of variants of the <italic>PXR</italic> gene in a sample of the Brazilian population. We found 11 polymorphisms in the <italic>PXR</italic> gene, including the 4306 C&#x0003e;G substitution in exon 4 that has not been previously described. This variant is not predicted to alter the splice site in exon 4 of the <italic>PXR</italic> gene and is unlikely to alter protein function.</p><p>The Brazilian population is highly heterogeneous, resulting from centuries of interbreeding among peoples from three continents: European colonizers (mostly Portuguese), African slaves, and native Indians.<xref ref-type="bibr" rid="b21-cln_66p1041">21</xref> Although Brazilians contain approximately 28% of African alleles, we found that the variant C79T (rs12727613), which occurs in 20% of alleles Africans, occurred at a much lower than expected frequency in our sample (2.1%). On the other hand, the &#x02013;25913 C&#x0003e;T (rs1523130) polymorphism that is present in 28% of African alleles was present at a significantly higher frequency in our population (50%, p &#x0200a;=&#x0200a; 0.003). We also found that the -6994T&#x0003e;C (rs2472677), which is present in 38% of African alleles, was significantly more frequent in the Brazilian alleles (46%, p &#x0200a;=&#x0200a; 0.03). Finally, the &#x02013;25913 C&#x0003e;T and &#x02013;6994T&#x0003e;C polymorphisms were not as frequent in the Brazilian alleles as in Caucasian alleles (p &#x0003c; 0.05).</p><p>Our results are distinctly clustered. This could represent the unique admixture of the regional subpopulation from the southeast region of Brazil, which has similar ancestral contributions from African (34%), European (31%), and Native American (33%) alleles, in contrast to the higher proportion of African lineages observed in the northeast region.<xref ref-type="bibr" rid="b21-cln_66p1041">21</xref>-<xref ref-type="bibr" rid="b23-cln_66p1041">23</xref></p><p>Our study emphasizes the population-dependent frequency of <italic>PXR</italic> polymorphisms. The polymorphism frequencies found in our sample differ greatly from those previously described in Caucasians and Africans. Our results suggest that variants in the <italic>PXR</italic> gene should be considered in pharmacogenetic studies involving Brazilians from the southeast region, since the miscegenation varies from region to region.</p></sec><sec><title>ACKNOWLEDGEMENTS</title><p>The authors gratefully acknowledge Mr. Ricardo de Paula for language editing.</p><p>This research was supported by grants from FAPESP # 05/04726-0 and 09/54238-2, RPP Moreira by FAPESP # 08/50959-4 and 09/54394-4, and Bachega TASS, Jorge AA, and Mendonca BB by CNPq #305117/2009-2, #301477/2009-4, and #301339/2008-9, respectively.</p></sec></body><back><ref-list><title>REFERENCES</title><ref id="b1-cln_66p1041"><label>1</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Ingelman-Sundberg</surname><given-names>M</given-names></name><name><surname>Oscarson</surname><given-names>M</given-names></name><name><surname>McLellan</surname><given-names>RA</given-names></name></person-group><article-title>Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment</article-title><source>Trends Pharmacol Sci</source><year>1999</year><volume>20</volume><fpage>342</fpage><lpage>9</lpage><ext-link ext-link-type="doi" xlink:href="10.1016/S0165-6147(99)01363-2">10.1016/S0165-6147(99)01363-2</ext-link><pub-id pub-id-type="pmid">10431214</pub-id></element-citation></ref><ref id="b2-cln_66p1041"><label>2</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Ozdemir</surname><given-names>V</given-names></name><name><surname>Kalow</surname><given-names>W</given-names></name><name><surname>Tang</surname><given-names>BK</given-names></name><name><surname>Paterson</surname><given-names>AD</given-names></name><name><surname>Walker</surname><given-names>SE</given-names></name><name><surname>Endrenyi</surname><given-names>L</given-names></name><etal/></person-group><article-title>Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method</article-title><source>Pharmacogenetics</source><year>2000</year><volume>10</volume><fpage>373</fpage><lpage>88</lpage><ext-link ext-link-type="doi" xlink:href="10.1097/00008571-200007000-00001">10.1097/00008571-200007000-00001</ext-link><pub-id pub-id-type="pmid">10898107</pub-id></element-citation></ref><ref id="b3-cln_66p1041"><label>3</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Evans</surname><given-names>WE</given-names></name><name><surname>Relling</surname><given-names>MV</given-names></name></person-group><article-title>Pharmacogenomics: translating functional genomics into rational therapeutics</article-title><source>Science</source><year>1999</year><volume>286</volume><fpage>487</fpage><lpage>91</lpage><ext-link ext-link-type="doi" xlink:href="10.1126/science.286.5439.487">10.1126/science.286.5439.487</ext-link><pub-id pub-id-type="pmid">10521338</pub-id></element-citation></ref><ref id="b4-cln_66p1041"><label>4</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Lamba</surname><given-names>J</given-names></name><name><surname>Lamba</surname><given-names>V</given-names></name><name><surname>Strom</surname><given-names>S</given-names></name><name><surname>Venkataramanan</surname><given-names>R</given-names></name><name><surname>Schuetz</surname><given-names>E</given-names></name></person-group><article-title>Novel single nucleotide polymorphisms in the promoter and intron 1 of human pregnane X receptor/NR1I2 and their association with CYP3A4 expression</article-title><source>Drug Metab Dispos</source><year>2008</year><volume>36</volume><fpage>169</fpage><lpage>81</lpage><ext-link ext-link-type="doi" xlink:href="10.1124/dmd.107.016600">10.1124/dmd.107.016600</ext-link><pub-id pub-id-type="pmid">17925385</pub-id></element-citation></ref><ref id="b5-cln_66p1041"><label>5</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Rebbeck</surname><given-names>TR</given-names></name><name><surname>Jaffe</surname><given-names>JM</given-names></name><name><surname>Walker</surname><given-names>AH</given-names></name><name><surname>Wein</surname><given-names>AJ</given-names></name><name><surname>Malkowicz</surname><given-names>SB</given-names></name></person-group><article-title>Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4</article-title><source>J Natl Cancer Inst</source><year>1998</year><volume>90</volume><fpage>1225</fpage><lpage>9</lpage><ext-link ext-link-type="doi" xlink:href="10.1093/jnci/90.16.1225">10.1093/jnci/90.16.1225</ext-link><pub-id pub-id-type="pmid">9719084</pub-id></element-citation></ref><ref id="b6-cln_66p1041"><label>6</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Ball</surname><given-names>SE</given-names></name><name><surname>Scatina</surname><given-names>J</given-names></name><name><surname>Kao</surname><given-names>J</given-names></name><name><surname>Ferron</surname><given-names>GM</given-names></name><name><surname>Fruncillo</surname><given-names>R</given-names></name><name><surname>Mayer</surname><given-names>P</given-names></name><etal/></person-group><article-title>Population distribution and effects on drug metabolism of a genetic variant in the 5&#x02032; promoter region of CYP3A4</article-title><source>Clin Pharmacol Ther</source><year>1999</year><volume>66</volume><fpage>288</fpage><lpage>94</lpage><ext-link ext-link-type="doi" xlink:href="10.1016/S0009-9236(99)70037-8">10.1016/S0009-9236(99)70037-8</ext-link><pub-id pub-id-type="pmid">10511065</pub-id></element-citation></ref><ref id="b7-cln_66p1041"><label>7</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Eiselt</surname><given-names>R</given-names></name><name><surname>Domanski</surname><given-names>TL</given-names></name><name><surname>Zibat</surname><given-names>A</given-names></name><name><surname>Mueller</surname><given-names>R</given-names></name><name><surname>Presecan-Siedel</surname><given-names>E</given-names></name><name><surname>Hustert</surname><given-names>E</given-names></name><etal/></person-group><article-title>Identification and functional characterization of eight CYP3A4 protein variants</article-title><source>Pharmacogenetics</source><year>2001</year><volume>11</volume><fpage>447</fpage><lpage>58</lpage><ext-link ext-link-type="doi" xlink:href="10.1097/00008571-200107000-00008">10.1097/00008571-200107000-00008</ext-link><pub-id pub-id-type="pmid">11470997</pub-id></element-citation></ref><ref id="b8-cln_66p1041"><label>8</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Bertilsson</surname><given-names>G</given-names></name><name><surname>Heidrich</surname><given-names>J</given-names></name><name><surname>Svensson</surname><given-names>K</given-names></name><name><surname>Asman</surname><given-names>M</given-names></name><name><surname>Jendeberg</surname><given-names>L</given-names></name><name><surname>Sydow-Backman</surname><given-names>M</given-names></name><etal/></person-group><article-title>Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction</article-title><source>Proc Natl Acad Sci U S A</source><year>1998</year><volume>95</volume><fpage>12208</fpage><lpage>13</lpage><ext-link ext-link-type="doi" xlink:href="10.1073/pnas.95.21.12208">10.1073/pnas.95.21.12208</ext-link><pub-id pub-id-type="pmid">9770465</pub-id></element-citation></ref><ref id="b9-cln_66p1041"><label>9</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Kliewer</surname><given-names>SA</given-names></name><name><surname>Moore</surname><given-names>JT</given-names></name><name><surname>Wade</surname><given-names>L</given-names></name><name><surname>Staudinger</surname><given-names>JL</given-names></name><name><surname>Watson</surname><given-names>MA</given-names></name><name><surname>Jones</surname><given-names>SA</given-names></name><etal/></person-group><article-title>An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway</article-title><source>Cell</source><year>1998</year><volume>92</volume><fpage>73</fpage><lpage>82</lpage><ext-link ext-link-type="doi" xlink:href="10.1016/S0092-8674(00)80900-9">10.1016/S0092-8674(00)80900-9</ext-link><pub-id pub-id-type="pmid">9489701</pub-id></element-citation></ref><ref id="b10-cln_66p1041"><label>10</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Lehmann</surname><given-names>JM</given-names></name><name><surname>McKee</surname><given-names>DD</given-names></name><name><surname>Watson</surname><given-names>MA</given-names></name><name><surname>Willson</surname><given-names>TM</given-names></name><name><surname>Moore</surname><given-names>JT</given-names></name><name><surname>Kliewer</surname><given-names>SA</given-names></name></person-group><article-title>The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions</article-title><source>J Clin Invest</source><year>1998</year><volume>102</volume><fpage>1016</fpage><lpage>23</lpage><ext-link ext-link-type="doi" xlink:href="10.1172/JCI3703">10.1172/JCI3703</ext-link><pub-id pub-id-type="pmid">9727070</pub-id></element-citation></ref><ref id="b11-cln_66p1041"><label>11</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Synold</surname><given-names>TW</given-names></name><name><surname>Dussault</surname><given-names>I</given-names></name><name><surname>Forman</surname><given-names>BM</given-names></name></person-group><article-title>The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux</article-title><source>Nat Med</source><year>2001</year><volume>7</volume><fpage>584</fpage><lpage>90</lpage><ext-link ext-link-type="doi" xlink:href="10.1038/87912">10.1038/87912</ext-link><pub-id pub-id-type="pmid">11329060</pub-id></element-citation></ref><ref id="b12-cln_66p1041"><label>12</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Kuehl</surname><given-names>P</given-names></name><name><surname>Green</surname><given-names>ED</given-names></name><name><surname>Touchman</surname><given-names>JW</given-names></name><name><surname>Watkins</surname><given-names>PB</given-names></name><name><surname>Daly</surname><given-names>A</given-names></name><etal/></person-group><article-title>The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants</article-title><source>Pharmacogenetics</source><year>2001</year><volume>11</volume><fpage>555</fpage><lpage>72</lpage><ext-link ext-link-type="doi" xlink:href="10.1097/00008571-200110000-00003">10.1097/00008571-200110000-00003</ext-link><pub-id pub-id-type="pmid">11668216</pub-id></element-citation></ref><ref id="b13-cln_66p1041"><label>13</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Svard</surname><given-names>J</given-names></name><name><surname>Spiers</surname><given-names>JP</given-names></name><name><surname>Mulcahy</surname><given-names>F</given-names></name><name><surname>Hennessy</surname><given-names>M</given-names></name></person-group><article-title>Nuclear Receptor-Mediated Induction of CYP450 by Antiretrovirals: Functional Consequences of NR1I2 (PXR) Polymorphisms and Differential Prevalence in Whites and Sub-Saharan Africans</article-title><source>J Acquir Immune Defic Syndr</source></element-citation></ref><ref id="b14-cln_66p1041"><label>14</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Wang</surname><given-names>XD</given-names></name><name><surname>Deng</surname><given-names>XY</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>JL</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>LZ</given-names></name><etal/></person-group><article-title>Single nucleotide polymorphisms of the pregnane x receptor gene in Han Chinese and a comparison with other ethnic populations</article-title><source>Pharmacology</source><year>2008</year><volume>81</volume><fpage>350</fpage><lpage>4</lpage><ext-link ext-link-type="doi" xlink:href="10.1159/000123687">10.1159/000123687</ext-link><pub-id pub-id-type="pmid">18391510</pub-id></element-citation></ref><ref id="b15-cln_66p1041"><label>15</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Wang</surname><given-names>XD</given-names></name><name><surname>Li</surname><given-names>JL</given-names></name><name><surname>Su</surname><given-names>QB</given-names></name><name><surname>Deng</surname><given-names>XY</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><etal/></person-group><article-title>A pharmacogenetic study of pregnane X receptor (NR1I2) in Han Chinese</article-title><source>Curr Drug Metab</source><year>2007</year><volume>8</volume><fpage>778</fpage><lpage>86</lpage><ext-link ext-link-type="doi" xlink:href="10.2174/138920007782798199">10.2174/138920007782798199</ext-link><pub-id pub-id-type="pmid">18220558</pub-id></element-citation></ref><ref id="b16-cln_66p1041"><label>16</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>King</surname><given-names>CR</given-names></name><name><surname>Xiao</surname><given-names>M</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Minton</surname><given-names>MR</given-names></name><name><surname>Addleman</surname><given-names>NJ</given-names></name><name><surname>Van Booven</surname><given-names>DJ</given-names></name><etal/></person-group><article-title>Identification of NR1I2 genetic variation using resequencing</article-title><source>Eur J Clin Pharmacol</source><year>2007</year><volume>63</volume><fpage>547</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">17404718</pub-id></element-citation></ref><ref id="b17-cln_66p1041"><label>17</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Xie</surname><given-names>W</given-names></name><name><surname>Krasowski</surname><given-names>MD</given-names></name></person-group><article-title>PXR: a xenobiotic receptor of diverse function implicated in pharmacogenetics</article-title><source>Pharmacogenomics</source><year>2008</year><volume>9</volume><fpage>1695</fpage><lpage>709</lpage><ext-link ext-link-type="doi" xlink:href="10.2217/14622416.9.11.1695">10.2217/14622416.9.11.1695</ext-link><pub-id pub-id-type="pmid">19018724</pub-id></element-citation></ref><ref id="b18-cln_66p1041"><label>18</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Hustert</surname><given-names>E</given-names></name><name><surname>Zibat</surname><given-names>A</given-names></name><name><surname>Presecan-Siedel</surname><given-names>E</given-names></name><name><surname>Eiselt</surname><given-names>R</given-names></name><name><surname>Mueller</surname><given-names>R</given-names></name><name><surname>Fuss</surname><given-names>C</given-names></name><etal/></person-group><article-title>Natural protein variants of pregnane X receptor with altered transactivation activity toward CYP3A4</article-title><source>Drug Metab Dispos</source><year>2001</year><volume>29</volume><fpage>1454</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11602521</pub-id></element-citation></ref><ref id="b19-cln_66p1041"><label>19</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Sandanaraj</surname><given-names>E</given-names></name><name><surname>Lal</surname><given-names>S</given-names></name><name><surname>Selvarajan</surname><given-names>V</given-names></name><name><surname>Ooi</surname><given-names>LL</given-names></name><name><surname>Wong</surname><given-names>ZW</given-names></name><name><surname>Wong</surname><given-names>NS</given-names></name><etal/></person-group><article-title>PXR pharmacogenetics: association of haplotypes with hepatic CYP3A4 and ABCB1 messenger RNA expression and doxorubicin clearance in Asian breast cancer patients</article-title><source>Clin Cancer Res</source><year>2008</year><volume>14</volume><fpage>7116</fpage><lpage>26</lpage><ext-link ext-link-type="doi" xlink:href="10.1158/1078-0432.CCR-08-0411">10.1158/1078-0432.CCR-08-0411</ext-link><pub-id pub-id-type="pmid">18981011</pub-id></element-citation></ref><ref id="b20-cln_66p1041"><label>20</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Siccardi</surname><given-names>M</given-names></name><name><surname>D'Avolio</surname><given-names>A</given-names></name><name><surname>Baietto</surname><given-names>L</given-names></name><name><surname>Gibbons</surname><given-names>S</given-names></name><name><surname>Sciandra</surname><given-names>M</given-names></name><name><surname>Colucci</surname><given-names>D</given-names></name><etal/></person-group><article-title>Association of a single-nucleotide polymorphism in the pregnane X receptor (PXR 63396C--&#x0003e;T) with reduced concentrations of unboosted atazanavir</article-title><source>Clin Infect Dis</source><year>2008</year><volume>47</volume><fpage>1222</fpage><lpage>5</lpage><ext-link ext-link-type="doi" xlink:href="10.1086/592304">10.1086/592304</ext-link><pub-id pub-id-type="pmid">18831695</pub-id></element-citation></ref><ref id="b21-cln_66p1041"><label>21</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Parra</surname><given-names>FC</given-names></name><name><surname>Amado</surname><given-names>RC</given-names></name><name><surname>Lambertucci</surname><given-names>JR</given-names></name><name><surname>Rocha</surname><given-names>J</given-names></name><name><surname>Antunes</surname><given-names>CM</given-names></name><name><surname>Pena</surname><given-names>SD</given-names></name></person-group><article-title>Color and genomic ancestry in Brazilians</article-title><source>Proc Natl Acad Sci U S A</source><year>2003</year><volume>100</volume><fpage>177</fpage><lpage>82</lpage><ext-link ext-link-type="doi" xlink:href="10.1073/pnas.0126614100">10.1073/pnas.0126614100</ext-link><pub-id pub-id-type="pmid">12509516</pub-id></element-citation></ref><ref id="b22-cln_66p1041"><label>22</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Alves-Silva</surname><given-names>J</given-names></name><name><surname>da Silva Santos</surname><given-names>M</given-names></name><name><surname>Guimaraes</surname><given-names>PE</given-names></name><name><surname>Ferreira</surname><given-names>AC</given-names></name><name><surname>Bandelt</surname><given-names>HJ</given-names></name><name><surname>Pena</surname><given-names>SD</given-names></name><etal/></person-group><article-title>The ancestry of Brazilian mtDNA lineages</article-title><source>Am J Hum Genet</source><year>2000</year><volume>67</volume><fpage>444</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">10873790</pub-id></element-citation></ref><ref id="b23-cln_66p1041"><label>23</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Carvalho-Silva</surname><given-names>DR</given-names></name><name><surname>Santos</surname><given-names>FR</given-names></name><name><surname>Rocha</surname><given-names>J</given-names></name><name><surname>Pena</surname><given-names>SD</given-names></name></person-group><article-title>The phylogeography of Brazilian Y-chromosome lineages</article-title><source>Am J Hum Genet</source><year>2001</year><volume>68</volume><fpage>281</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">11090340</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="t1-cln_66p1041" position="float"><label>Table 1</label><caption><p>Allelic frequency of polymorphisms in the <italic>PXR</italic> gene in Brazilians compared to Asians, Caucasians, and Africans.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Location</td><td align="left" valign="bottom" rowspan="1" colspan="1">dbSNP</td><td align="left" valign="bottom" rowspan="1" colspan="1">*Position in AF364606</td><td align="left" valign="bottom" rowspan="1" colspan="1">Amino Acid Change</td><td colspan="2" align="center" valign="bottom" rowspan="1">Asians</td><td colspan="2" align="center" valign="bottom" rowspan="1">Caucasians</td><td colspan="2" align="center" valign="bottom" rowspan="1">Africans<xref ref-type="table-fn" rid="tfn1-cln_66p1041">a</xref></td><td colspan="2" align="center" valign="bottom" rowspan="1">This study</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="bottom" rowspan="1" colspan="1"/><td align="center" valign="bottom" rowspan="1" colspan="1"/><td align="center" valign="bottom" rowspan="1" colspan="1"/><td align="center" valign="bottom" rowspan="1" colspan="1">n&#x000b0;</td><td align="center" valign="bottom" rowspan="1" colspan="1">Frequency</td><td align="center" valign="bottom" rowspan="1" colspan="1">n&#x000b0;</td><td align="center" valign="bottom" rowspan="1" colspan="1">Frequency</td><td align="center" valign="bottom" rowspan="1" colspan="1">n&#x000b0;</td><td align="center" valign="bottom" rowspan="1" colspan="1">Frequency</td><td align="center" valign="bottom" rowspan="1" colspan="1">n&#x000b0;</td><td align="center" valign="bottom" rowspan="1" colspan="1">Frequency</td></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">5&#x02032;UTR</td><td align="left" valign="top" rowspan="1" colspan="1">rs1523130</td><td align="left" valign="top" rowspan="1" colspan="1">-25913 C&#x0003e;T</td><td align="left" valign="top" rowspan="1" colspan="1">-</td><td align="char" char="." valign="top" rowspan="1" colspan="1">80<sup>1</sup></td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.67</td><td align="char" char="." valign="top" rowspan="1" colspan="1">80<sup>1</sup></td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.70</td><td align="char" char="." valign="top" rowspan="1" colspan="1">80<sup>1</sup></td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.28</td><td align="char" char="." valign="top" rowspan="1" colspan="1">234</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.50</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Intron 1</td><td align="left" valign="top" rowspan="1" colspan="1">rs2472677</td><td align="left" valign="top" rowspan="1" colspan="1">-6994 C&#x0003e;T</td><td align="left" valign="top" rowspan="1" colspan="1">-</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">92<sup>4</sup></td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.62</td><td align="char" char="." valign="top" rowspan="1" colspan="1">714<sup>#</sup></td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.381</td><td align="char" char="." valign="top" rowspan="1" colspan="1">234</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.457</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Exon 2</td><td align="left" valign="top" rowspan="1" colspan="1">rs12727613</td><td align="left" valign="top" rowspan="1" colspan="1">79 C&#x0003e;T</td><td align="left" valign="top" rowspan="1" colspan="1">Pro27Ser</td><td align="char" char="." valign="top" rowspan="1" colspan="1">80<sup>1</sup></td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">300<sup>2</sup></td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">66<sup>3</sup></td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.20</td><td align="char" char="." valign="top" rowspan="1" colspan="1">234</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.021</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Exon 2</td><td align="left" valign="top" rowspan="1" colspan="1">rs12721607</td><td align="left" valign="top" rowspan="1" colspan="1">106 G&#x0003e;A</td><td align="left" valign="top" rowspan="1" colspan="1">Gly36Arg</td><td align="char" char="." valign="top" rowspan="1" colspan="1">80<sup>1</sup></td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">80<sup>1</sup></td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.05</td><td align="char" char="." valign="top" rowspan="1" colspan="1">80<sup>1</sup></td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.04</td><td align="char" char="." valign="top" rowspan="1" colspan="1">234</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.013</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic>Exon 4</italic></td><td align="left" valign="top" rowspan="1" colspan="1">-</td><td align="left" valign="top" rowspan="1" colspan="1"><italic>4306 C&#x0003e;G</italic></td><td align="left" valign="top" rowspan="1" colspan="1"><italic>Arg156Arg</italic></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">234</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.013</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Exon 4</td><td align="left" valign="top" rowspan="1" colspan="1">rs12721608</td><td align="left" valign="top" rowspan="1" colspan="1">4321 G&#x0003e;A</td><td align="left" valign="top" rowspan="1" colspan="1">Gln122Arg</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">144<sup>3</sup></td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.01</td><td align="char" char="." valign="top" rowspan="1" colspan="1">714<sup>#</sup></td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">234</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.012</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Exon 4</td><td align="left" valign="top" rowspan="1" colspan="1">rs12721611</td><td align="left" valign="top" rowspan="1" colspan="1">4447 T&#x0003e;C</td><td align="left" valign="top" rowspan="1" colspan="1">Thr164Thr</td><td align="char" char="." valign="top" rowspan="1" colspan="1">80<sup>1</sup></td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">80<sup>1</sup></td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">80<sup>1</sup></td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.03</td><td align="char" char="." valign="top" rowspan="1" colspan="1">234</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.008</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Exon 5</td><td align="left" valign="top" rowspan="1" colspan="1">rs12721600</td><td align="left" valign="top" rowspan="1" colspan="1">4499 C&#x0003e;T</td><td align="left" valign="top" rowspan="1" colspan="1">Gly220Gly</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">234</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.008</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Exon 6</td><td align="left" valign="top" rowspan="1" colspan="1">rs12721612</td><td align="left" valign="top" rowspan="1" colspan="1">4773 G&#x0003e;A</td><td align="left" valign="top" rowspan="1" colspan="1">Gly317Gly</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">234</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.004</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Intron 6</td><td align="left" valign="top" rowspan="1" colspan="1">rs2276707</td><td align="left" valign="top" rowspan="1" colspan="1">8055 C&#x0003e;T</td><td align="left" valign="top" rowspan="1" colspan="1">-</td><td align="char" char="." valign="top" rowspan="1" colspan="1">80<sup>1</sup></td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.51</td><td align="char" char="." valign="top" rowspan="1" colspan="1">150<sup>5</sup></td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.15</td><td align="char" char="." valign="top" rowspan="1" colspan="1">22<sup>5</sup></td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.18</td><td align="char" char="." valign="top" rowspan="1" colspan="1">234</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.125</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Exon 8</td><td align="left" valign="top" rowspan="1" colspan="1">rs59152710</td><td align="left" valign="top" rowspan="1" colspan="1">8528 G&#x0003e;A</td><td align="left" valign="top" rowspan="1" colspan="1">Ala370Thr</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">312<sup>2</sup></td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">64<sup>2</sup></td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.016</td><td align="char" char="." valign="top" rowspan="1" colspan="1">234</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.004</td></tr></tbody></table><table-wrap-foot><fn id="tfn1-cln_66p1041"><label>a</label><p>African-American population. n&#x000b0;: number of alleles. Data from Asians, Caucasians, and Africans was obtained from <sup>1</sup>King et al. 2007, <sup>2</sup>Hustert et al. 2001, <sup>3</sup>Wang et al. 2008, <sup>4</sup>Lamba et al. 2008, and <sup>5</sup>Zhang et al. 2008. <sup>#</sup>Data from sub-Saharan Africans (Svard et al. 2010). Italics: new variant. *Position in relation to translation start site of PXR (NR1I2): GenBank Accession AF364606.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t2-cln_66p1041" position="float"><label>Table 2</label><caption><p>Genotypic frequency of polymorphisms in the <italic>PXR</italic> gene in Brazilians.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Location</td><td align="center" valign="bottom" rowspan="1" colspan="1">dbSNP</td><td align="center" valign="bottom" rowspan="1" colspan="1">*Position in AF364606</td><td align="left" valign="bottom" rowspan="1" colspan="1"/><td align="center" valign="bottom" rowspan="1" colspan="1">Frequency</td></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">5&#x02032;UTR</td><td align="left" valign="top" rowspan="1" colspan="1">rs1523130</td><td align="left" valign="top" rowspan="1" colspan="1">-25913 C&#x0003e;T</td><td align="left" valign="top" rowspan="1" colspan="1">CC</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.325</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">CT</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.35</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">TT</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.325</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Intron 1</td><td align="left" valign="top" rowspan="1" colspan="1">rs2472677</td><td align="left" valign="top" rowspan="1" colspan="1">-6994 C&#x0003e;T</td><td align="left" valign="top" rowspan="1" colspan="1">CC</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.368</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">CT</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.352</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">TT</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.282</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Exon 2</td><td align="left" valign="top" rowspan="1" colspan="1">rs12727613</td><td align="left" valign="top" rowspan="1" colspan="1">79 C&#x0003e;T</td><td align="left" valign="top" rowspan="1" colspan="1">CC</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.957</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">CT</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.043</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">TT</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Exon 2</td><td align="left" valign="top" rowspan="1" colspan="1">rs12721607</td><td align="left" valign="top" rowspan="1" colspan="1">106 G&#x0003e;A</td><td align="left" valign="top" rowspan="1" colspan="1">GG</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.974</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GA</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.026</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">AA</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic>Exon 4</italic></td><td align="left" valign="top" rowspan="1" colspan="1"><italic>-</italic></td><td align="left" valign="top" rowspan="1" colspan="1"><italic>4306 C&#x0003e;G</italic></td><td align="left" valign="top" rowspan="1" colspan="1"><italic>CC</italic></td><td align="char" char="." valign="top" rowspan="1" colspan="1"><italic>0.974</italic></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"><italic>CG</italic></td><td align="char" char="." valign="top" rowspan="1" colspan="1"><italic>0.026</italic></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"><italic>GG</italic></td><td align="char" char="." valign="top" rowspan="1" colspan="1"><italic>0</italic></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Exon 4</td><td align="left" valign="top" rowspan="1" colspan="1">rs12721608</td><td align="left" valign="top" rowspan="1" colspan="1">4321 G&#x0003e;A</td><td align="left" valign="top" rowspan="1" colspan="1">GG</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.974</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GA</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.026</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">AA</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Exon 4</td><td align="left" valign="top" rowspan="1" colspan="1">rs12721611</td><td align="left" valign="top" rowspan="1" colspan="1">4447 T&#x0003e;C</td><td align="left" valign="top" rowspan="1" colspan="1">TT</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.983</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">TC</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.017</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">CC</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Exon 5</td><td align="left" valign="top" rowspan="1" colspan="1">rs12721600</td><td align="left" valign="top" rowspan="1" colspan="1">4499 C&#x0003e;T</td><td align="left" valign="top" rowspan="1" colspan="1">CC</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.983</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">CT</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.017</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">TT</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Exon 6</td><td align="left" valign="top" rowspan="1" colspan="1">rs12721612</td><td align="left" valign="top" rowspan="1" colspan="1">4773 G&#x0003e;A</td><td align="left" valign="top" rowspan="1" colspan="1">GG</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.992</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GA</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.08</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">AA</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Intron 6</td><td align="left" valign="top" rowspan="1" colspan="1">rs2276707</td><td align="left" valign="top" rowspan="1" colspan="1">8055 C&#x0003e;T</td><td align="left" valign="top" rowspan="1" colspan="1">CC</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.769</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">CT</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.214</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">TT</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.017</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Exon 8</td><td align="left" valign="top" rowspan="1" colspan="1">rs59152710</td><td align="left" valign="top" rowspan="1" colspan="1">8528 G&#x0003e;A</td><td align="left" valign="top" rowspan="1" colspan="1">GG</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.992</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GA</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.08</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">AA</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td></tr></tbody></table><table-wrap-foot><fn id="tfn2-cln_66p1041"><p>Italics: new variant, *Position in relation to translation start site of PXR (NR1I2): GenBank Accession AF364606.</p></fn></table-wrap-foot></table-wrap></floats-group></article>